EUVIMEDEUVIMED entdecken
Crossref

Sophora tonkinensis reprograms tumor-associated macrophages to M1-like phenotype and exerts anti-hepatocellular carcinoma effects

Siqi Huang, Jincai Wen, Xiaoyan Chen, Xianling Wang, Yuanyuan Guo, Lu Liu, Caiping He, Zongliang Lu, Ang Huang, Xiaoyan Zhan, Jun Zhao, Xiaohe Xiao und 1 weitere

Molecular Immunology · 2026-03 · 191 · 49-59

DOI: 10.1016/j.molimm.2026.02.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Immunology, 2026-03. Verfasst von Siqi Huang und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Department of Hepatology, the Fifth Medical Center of C…. Hauptthemen laut MEDLINE: Sophora, Tumor-Associated Macrophages, Plant Extracts, Liver Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality, Beijing Nova Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: Sophora tonkinensis radix et rhizoma is a medicinal herb traditionally used to treat inflammatory diseases and various types of cancer, previous phytochemistry studies have identified abundant alkaloids and flavonoids as the major bioactive components with anti-inflammatory, anti-tumor, hepatoprotective and immunomodulatory pharmacological effects, but their effects on Tumor-associated macrophages (TAMs) and the tumor immune microenvironment have not been systematically explored. AIM OF THE STUDY: This work aimed to establish whether a standardized extract of Sophora tonkinensis (STE) can halt IL-4-driven M2 macrophage polarization, reprogram established M2-like tumor-associated macrophages toward a pro-inflammatory M1-like phenotype, and clarify the underlying molecular mechanisms and in vivo efficacy of these immunomodulatory actions. MATERIALS AND METHODS: Bone-marrow-derived macrophages (BMDMs) were polarized to an M2 phenotype and subsequently treated with STE. Expression of the M1/M2 markers Arg-1, CD206, iNOS, and CD86 in these macrophages was quantified by immunoblotting, qPCR, and flow cytometry. The impact of STE-pretreated M2-conditioned medium on the proliferation, migration, and invasion of Hepa 1-6 cells was then examined. H22 cells were subcutaneously inoculated into Balb/c mice to assess STE's effects on the macrophage landscape within the tumor immune microenvironment and to evaluate its antitumor efficacy. RESULTS: STE dose-dependently suppressed IL-4-induced Arg-1 and CD206 while up-regulating iNOS and CD86, indicating a blockade of M2 polarization and a shift toward an M1 signature. Mechanistically, STE markedly increased JAK1 and STAT1 phosphorylation. Functionally, it potently inhibited invasion and migration of Hepa 1-6 cells. In tumor-bearing mice, robust suppression of tumor growth was accompanied by a pronounced reduction in M2-like TAMs and a reciprocal increase in M1-like macrophages within the tumor microenvironment. CONCLUSION: STE reprograms TAMs via the JAK1/STAT1 axis and exhibits robust antitumor activity, underscoring its promise as a natural, macrophage-targeted immunotherapeutic that warrants further investigation for integration into cancer treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SophoraTumor-Associated MacrophagesPlant ExtractsLiver NeoplasmsCarcinoma, HepatocellularMacrophagesAnimalsMicePhenotypeTumor MicroenvironmentCell Line, TumorCell MovementHumansMice, Inbred C57BLCell ProliferationMacrophage ActivationMice, Inbred BALB CMale

Stichwörter der Autor:innen

M1 macrophageM2 macrophageSophora tonkinensis ExtractTumor-Associated Macrophages

Substanzen

Plant Extracts

Autor:innen und Institutionen

  • School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China; Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
  • School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
  • Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China; School of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
  • Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
  • Department of Gastroenterology and Hepatology, the First Medical Center of PLA General Hospital, China.
  • Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China. Electronic address: zhj68@263.net.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Beijing Municipality
  • Beijing Nova Program

Zitieren

APA

Huang, S., Wen, J., Chen, X., Wang, X., Guo, Y., Liu, L., He, C., Lu, Z., Huang, A., Zhan, X., Zhao, J., Xiao, X., & Bai, Z. (2026). Sophora tonkinensis reprograms tumor-associated macrophages to M1-like phenotype and exerts anti-hepatocellular carcinoma effects. Molecular Immunology, 191, 49-59. https://doi.org/10.1016/j.molimm.2026.02.003

Vancouver

Huang S, Wen J, Chen X, Wang X, Guo Y, Liu L, et al. Sophora tonkinensis reprograms tumor-associated macrophages to M1-like phenotype and exerts anti-hepatocellular carcinoma effects. Molecular Immunology. 2026;191:49-59. doi:10.1016/j.molimm.2026.02.003

BibTeX
@article{Huang2026,
  author = {Huang, Siqi and Wen, Jincai and Chen, Xiaoyan and Wang, Xianling and Guo, Yuanyuan and Liu, Lu and He, Caiping and Lu, Zongliang and Huang, Ang and Zhan, Xiaoyan and Zhao, Jun and Xiao, Xiaohe and Bai, Zhaofang},
  title = {Sophora tonkinensis reprograms tumor-associated macrophages to M1-like phenotype and exerts anti-hepatocellular carcinoma effects},
  journal = {Molecular Immunology},
  year = {2026},
  volume = {191},
  pages = {49--59},
  doi = {10.1016/j.molimm.2026.02.003}
}
Kostenlos starten →